Cargando…

Increasing cefazolin use for surgical prophylaxis in penicillin-allergy–labeled patients

OBJECTIVE: Penicillin (PCN) allergy labels affect antimicrobial selection for surgical prophylaxis. We aimed to increase the percentage of cefazolin usage in patients with PCN allergy labels undergoing orthopedic surgery from 50% to 80%. DESIGN: Quality improvement initiative. SETTING: Children’s Me...

Descripción completa

Detalles Bibliográficos
Autores principales: VanderVelde, Kathryn A., Suppes, Sarah L., Gibbs, Katherine A., Latz, Kevin H., Vanderpool, Angela C., El Feghaly, Rana E., Goldman, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879898/
https://www.ncbi.nlm.nih.gov/pubmed/36714293
http://dx.doi.org/10.1017/ash.2022.360
Descripción
Sumario:OBJECTIVE: Penicillin (PCN) allergy labels affect antimicrobial selection for surgical prophylaxis. We aimed to increase the percentage of cefazolin usage in patients with PCN allergy labels undergoing orthopedic surgery from 50% to 80%. DESIGN: Quality improvement initiative. SETTING: Children’s Mercy Kansas City (CMKC), a freestanding children’s hospital. PATIENTS: Children scheduled for an orthopedic surgery (excluding spinal surgery) at CMKC who had a PCN allergy label and received a perioperative antibiotic. METHODS: No standardized process existed to identify and clarify PCN-allergic–labeled patients preoperatively. We developed a process for patient identification combined with a pharmacist phone interview for PCN allergy clarification. In plan–do–study–act (PDSA) part 1, we implemented a computer-generated patient list. In PDSA part 2, we combined automated identification with a phone interview. In PDSA part 3, we enhanced the patient list, making it timely and concise. In PDSA part 4, we included a PCN allergy clarification electronic survey to caregivers via the electronic medical record. RESULTS: Cefazolin use in PCN-allergic surgical patients increased from 50% to 74% following interventions. Patients who had their PCN allergy label clarified were 4 times more likely to receive cefazolin compared to those whose allergy labels were not clarified (OR, 4.21; 95% CI, 1.68–11.61; P = 0.003). Moreover, 90% of patients received cefazolin when their PCN allergy was clarified and cefazolin was recommended. When a PCN allergy label was not clarified, only 59% of patients received cefazolin. CONCLUSIONS: Appropriate clarification and documentation of PCN allergy labels increases the use of cefazolin for surgical prophylaxis.